BioAsia 2026

NorthX Biologics will take part in BioAsia 2026, one of Asia’s largest life science and biotechnology conventions, held on 17–18 February 2026 at the HITEX Exhibition Centre in Hyderabad, India. The conference convenes global leaders from industry, research, healthcare, and policy to discuss innovation across biopharma and advanced therapies, and NorthX Biologics’ presence underscores its engagement with the international life sciences community and emerging markets.

When: February 17-18, 2026
Where: Hyderabad, India

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn